MicroRNA-361-3p Inhibit the Progression of Lymphoma by the Wnt/β-Catenin Signaling Pathway.
Hui ZhouHuifeng TangNing LiHang ChenXiaohui ChenLei GuLiang ZhangGuoyan TianDiehong TaoPublished in: Cancer management and research (2020)
Our data indicate that miR-361-3p inhibits the Wnt/β-catenin protein signal by locking Wnt10A, which is an important factor in inhibiting the tumor in the pathogenesis of lymphoma. The miR-361-3p/Wnt10A axis may be a promising target for the treatment of lymphoma.